MK-8294

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-8294, covering 2026-03-16 to 2026-03-16. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001) [Phase 1]